Middle Meningeal Artery Embolization: A New Hope for Migraines?
- MigraineMind
- Nov 5, 2025
- 1 min read
Research Summary
A new study published in the International Journal of Surgery explores the potential of middle meningeal artery embolization (MMAE) as a treatment for migraines. Conducted with 15 participants, this pilot study focused on individuals with severe, medication-resistant migraines. Participants underwent the MMAE procedure using coils, targeting the side of the head with predominant symptoms. Over 90 days post-procedure, significant improvements were noted in migraine severity and disability scores, with decreased medication use. Although MMAE appears safe and potentially effective, the study’s small size and design limit broader applicability. Further randomized controlled trials are needed to confirm these findings.
Study Details
👥 Research Team: Xu K et al.
📚 Published In: Int J Surg
📅 Publication Date: 2025 Nov 4
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.